Ország: Új-Zéland
Nyelv: angol
Forrás: Medsafe (Medicines Safety Authority)
Chlorphenamine maleate 2mg (From Compap CPM-0117); Paracetamol 500mg (180.92mg from Compap L-0093, 319.08mg from Compap CPM-0117); Phenylephrine hydrochloride 5mg equivalent to phenylephrine 4.1 mg; ;
JNTL Consumer Health (New Zealand) Limited
Chlorphenamine maleate 2 mg (From Compap CPM-0117)
Film coated tablet
Active: Chlorphenamine maleate 2mg (From Compap CPM-0117) Paracetamol 500mg (180.92mg from Compap L-0093, 319.08mg from Compap CPM-0117) Phenylephrine hydrochloride 5mg equivalent to phenylephrine 4.1 mg Excipient: Colloidal silicon dioxide Crospovidone Balance of Compap L-0093 (as Pregelatinised starch, Stearic acid, Povidone and Crospovidone) hydrous Balance of Compap CPM-0117 (as Pregelatinised starch, Stearic acid and Povidone) hydrous Microcrystalline cellulose Opadry orange 85F63129 Pregelatinised maize starch Stearic acid
Pharmacy only
Kongo Chemical Co., Ltd
For the temporary relief of sinus headache, pain, congestion, and allergic symptoms such as sneezing, blocked or runny nose, itching and watery eyes.
Package - Contents - Shelf Life: Blister pack, PVD/PVDC and Al foil - 24 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVD/PVDC and Al foil - 48 tablets - 36 months from date of manufacture stored at or below 30°C
2013-12-16